PPARs as drug targets to modulate inflammatory responses?
about
Peroxisome proliferator-activated receptors (PPARs) and ovarian function--implications for regulating steroidogenesis, differentiation, and tissue remodeling.Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2bAlteration of energy substrates and ROS production in diabetic cardiomyopathyEffects of Ranolazine on Astrocytes and Neurons in Primary CultureRoles of PPARγ/NF-κB signaling pathway in the pathogenesis of intrahepatic cholestasis of pregnancy.Activation of peroxisome proliferator-activated receptor alpha in human peripheral blood mononuclear cells reveals an individual gene expression profile responseRedox regulation, NF-kappaB, and atrial fibrillation.Intertwining threshold settings, biological data and database knowledge to optimize the selection of differentially expressed genes from microarrayThe peroxisome proliferator-activated receptor gamma system regulates ultraviolet B-induced prostaglandin e(2) production in human epidermal keratinocytes.Association between the Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma 2 and inflammatory bowel disease: a meta-analysis.Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel diseaseMetabolic stress, reactive oxygen species, and arrhythmia.Activation of central PPAR-γ attenuates angiotensin II-induced hypertension.Oxidized glycerophosphocholines as biologically active mediators for ultraviolet radiation-mediated effects.Non-Esterified Fatty Acids Profiling in Rheumatoid Arthritis: Associations with Clinical Features and Th1 Response.PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages.N-Acetylcysteine attenuates tumor necrosis factor alpha levels in autoimmune inner ear disease patientsLimiting inflammatory responses during activation of innate immunity.Combinatorial roles of nuclear receptors in inflammation and immunity.The ω3-polyunsaturated fatty acid derivatives AVX001 and AVX002 directly inhibit cytosolic phospholipase A(2) and suppress PGE(2) formation in mesangial cellsMolecular mechanisms responsible for the reduced expression of cholesterol transporters from macrophages by low-dose endotoxinPPARgamma, a lipid-activated transcription factor as a regulator of dendritic cell function.Antioxidized LDL antibodies are associated with different metabolic pathways in patients with atherosclerotic plaque and type 2 diabetes.Anti-inflammatory and immune therapy for Alzheimer's disease: current status and future directions.Nuclear receptors and inflammatory diseases.Potential Therapeutic Targets for PPARgamma after Spinal Cord Injury.Peroxisome proliferator-activated receptor-gamma activation suppresses HIV-1 replication in an animal model of encephalitis.Animal models of catheter-induced intimal hyperplasia in type 1 and type 2 diabetes and the effects of pharmacologic intervention.Activation of toll-like receptors and inflammasome complexes in the diabetic cardiomyopathy-associated inflammation.Where Does Inflammation Fit?Palmitoleic acid (n-7) attenuates the immunometabolic disturbances caused by a high-fat diet independently of PPARαHuman dendritic cell activities are modulated by the omega-3 fatty acid, docosahexaenoic acid, mainly through PPAR(gamma):RXR heterodimers: comparison with other polyunsaturated fatty acids.
P2860
Q21245560-85F4C3FD-0060-4398-9FBD-BCA3921DBA7EQ25257883-6D795495-E90B-4A34-84AB-F818A1894FB1Q27014882-1E4D3305-E62E-44CB-A120-DD3C3D58FAC1Q28550579-7BED926D-87E7-4B3E-B493-092FCBA08AFFQ31149202-B406A28A-576A-4A18-B791-3268920A2E7AQ33339707-02CEB08F-551C-4DC1-8717-63697E6825FDQ33644314-8C99B09B-3463-4934-845F-06EE0DF48E5BQ33728115-9B489D2E-AF89-4F24-AD3F-A3CDC8EB7BB7Q33865064-338C654B-BA1D-4562-A325-808BAEE6556EQ34140665-097C098D-5081-493E-8DED-81E5E57BBF48Q34804346-EBC682DA-A49F-44F5-874E-579062AC76E6Q35690954-DD4A4771-C4FF-4648-A6A2-61B498DEA450Q35841988-F61FCABD-B5EB-4B21-B6EB-746FBB21EAD7Q35932617-FAAC3E76-CD8E-411E-A4F4-ED6083EA5BCFQ36093887-D04E9597-2D94-45CC-BED8-A1556DB6317EQ36171381-A588169A-B1CC-4336-BE85-16A82BFA20FBQ36296514-D8C51FB6-A702-4670-8B97-8C4458046E21Q36348742-7324A622-3EC7-486E-A2BB-9C29B107C2AEQ36403404-AB694036-8875-4C53-B81B-E88DB223BF28Q36476743-A06712FC-CAFE-467F-BD14-5D06746C3C00Q36534100-2CEC11BC-BBC4-4F17-A92F-3D039871F581Q36693982-FDE24D35-0463-4F73-8044-5F184EB075B5Q36720253-EF603ACB-8367-49A8-8CFB-EB75F138DC75Q37101754-AF85AEE0-F259-4BF1-A705-C8309586E8B1Q37122891-2891CB8D-A95A-4701-BA0B-C549AE4DBBE2Q37134018-37F59FD5-4EA8-427A-AEEC-44C99645C5CAQ37208433-945817D3-A3E3-450A-A337-DB1060D88C87Q37367896-F5825958-DC40-485F-849F-98EEBE8CEB23Q37679639-C694A679-99D7-42F7-BCD1-A910030FB109Q38639570-2A5E552D-0E58-4DE9-8684-705E96A4C2D4Q41829683-35412A3E-05ED-408E-BDE4-3FFE25D8FBE9Q46479941-DC5EA335-2D89-4132-B8F5-C2861A4537D6
P2860
PPARs as drug targets to modulate inflammatory responses?
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
PPARs as drug targets to modulate inflammatory responses?
@ast
PPARs as drug targets to modulate inflammatory responses?
@en
type
label
PPARs as drug targets to modulate inflammatory responses?
@ast
PPARs as drug targets to modulate inflammatory responses?
@en
prefLabel
PPARs as drug targets to modulate inflammatory responses?
@ast
PPARs as drug targets to modulate inflammatory responses?
@en
P2093
P356
P1476
PPARs as drug targets to modulate inflammatory responses?
@en
P2093
Liliane Michalik
Raphaël Genolet
Walter Wahli
P304
P356
10.2174/1568010042634578
P577
2004-12-01T00:00:00Z